Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: RE: Yes, they are. Ometepan

RE: Yes, they are. Ometepan

posted on Mar 28, 2006 04:32PM
I have no problems with receiving dividends, nor concerns about management strategy. I do, however, wonder why there are so many calls for share buy-backs when Lincoln/Swartz retain so many warrants - they are restricted to 9.99% holdngs, reducing the O/S means it takes even longer for them to convert.

Be well

Share
New Message
Please login to post a reply